Sri Kosuri
CIK 2043887 · View on SEC EDGAR ↗
First SEC filing: June 15, 2026 · Latest: June 15, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 11, 2026 | DNA | A | 25,000 | — | — | 25,000 Direct | — | Acquired | (price as of 2026-08-20) |
| June 12, 2025 | DNA | A | 34,375 | — | — | 34,375 Direct | — | Acquired | (price as of 2026-08-20) |
| June 11, 2025 | DNA | M | 24,067 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| June 11, 2025 | DNA | M | 24,067 | — | — | 24,067 Direct | — | Acquired | (price as of 2026-08-20) |
| Nov. 6, 2024 | DNA | A | 24,067 | — | — | 24,067 Direct | — | Acquired | (price as of 2026-08-20) |
| Nov. 6, 2024 | DNA | A | 30,911 | — | — | 30,911 Direct | — | Acquired | (price as of 2026-08-20) |
| Nov. 6, 2024 | DNA | A | 60,240 | — | — | 60,240 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 11, 2026 | DNA | Restricted Stock Units | Class A Common Stock (25,000) | — | — | 25,000 | Acquired |
| June 12, 2025 | DNA | Stock Option | Class A Common Stock (34,375) | $9.29 | June 12, 2035 | 34,375 | Acquired |
| June 11, 2025 | DNA | Restricted Stock Units | Class A Common Stock (24,067) | — | — | 24,067 | Disposed |
| Nov. 6, 2024 | DNA | Restricted Stock Units | Class A Common Stock (24,067) | — | — | 24,067 | Acquired |
| Nov. 6, 2024 | DNA | Stock Option | Class A Common Stock | $8.31 | Nov. 6, 2034 | 30,911 | Acquired |
| Nov. 6, 2024 | DNA | Stock Option | Class A Common Stock | $8.31 | Nov. 6, 2034 | 60,240 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).